Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.

Our newly proposed risk model based on combinatorial mRNA and microRNA expression has potential clinical utility as a prognostic indicator of recurrence. These findings should facilitate earlier prediction of recurrence with implications for improving patient outcome by tailoring treatment to disease risk and increasing post-treatment surveillance.